Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes

  1. Paul J. Norman1,
  2. Laurent Abi-Rached1,
  3. Ketevan Gendzekhadze1,
  4. John A. Hammond1,
  5. Achim K. Moesta1,
  6. Deepti Sharma1,
  7. Thorsten Graef1,
  8. Karina L. McQueen1,
  9. Lisbeth A. Guethlein1,
  10. Christine V.F. Carrington2,
  11. Dasdayanee Chandanayingyong3,
  12. Yih-Hsin Chang4,
  13. Catalina Crespí5,
  14. Güher Saruhan-Direskeneli6,
  15. Kamran Hameed7,
  16. Giorgi Kamkamidze8,
  17. Kwadwo A. Koram9,
  18. Zulay Layrisse10,
  19. Nuria Matamoros5,
  20. Joan Milà5,
  21. Myoung Hee Park11,
  22. Ramasamy M. Pitchappan12,
  23. D. Dan Ramdath2,
  24. Ming-Yuh Shiau13,
  25. Henry A.F. Stephens14,
  26. Siske Struik15,
  27. Dolly Tyan16,
  28. David H. Verity17,
  29. Robert W. Vaughan18,
  30. Ronald W. Davis19,
  31. Patricia A. Fraser20,
  32. Eleanor M. Riley15,
  33. Mostafa Ronaghi19 and
  34. Peter Parham1,21
  1. 1 Department of Structural Biology and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California 94305, USA;
  2. 2 Department of Preclinical Sciences, Faculty of Medical Sciences, University of West Indies, St. Augustine, Trinidad and Tobago;
  3. 3 Department of Transfusion Medicine, Faculty of Medicine and Siriraj Hospital, Mahidol University, Bangkok 10070, Thailand;
  4. 4 School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan;
  5. 5 Immunology Service, Hospital Universitari Son Dureta, Palma 07014, Spain;
  6. 6 Istanbul Medical Faculty, Department of Physiology, Istanbul University, Istanbul 34093, Turkey;
  7. 7 Department of Medicine, Aga Khan University Hospital, Karachi 74800, Pakistan;
  8. 8 Department of Clinical Immunology, REA Centre, Tbilisi 0160, Georgia;
  9. 9 Noguchi Memorial Institute for Medical Research, University of Ghana, Legon LG581, Ghana;
  10. 10 Centre of Experimental Medicine “Miguel Layrisse” Venezuelan Research Institute (IVIC), Caracas 21827, Venezuela;
  11. 11 Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea;
  12. 12 Centre for Advanced Studies in Functional Genomics, School of Biological Sciences, Madurai Kamaraj University Madurai 625-021, India;
  13. 13 Hung Kuang University, Taichung 433, Taiwan;
  14. 14 Centre for Nephrology and The Anthony Nolan Trust, Royal Free and University College Medical School, London NW3 2QG, United Kingdom;
  15. 15 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom;
  16. 16 Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA;
  17. 17 Moorfields Eye Hospital, London EC1V 2PD, United Kingdom;
  18. 18 Clinical Transplantation Laboratory, Guy's and St. Thomas' Foundation Trust and King's College, London SE1 9RT, United Kingdom;
  19. 19 Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, California 94304, USA;
  20. 20 Immune Disease Institute, Boston, Massachusetts 02115, USA

    Abstract

    Natural killer (NK) cells contribute to the essential functions of innate immunity and reproduction. Various genes encode NK cell receptors that recognize the major histocompatibility complex (MHC) Class I molecules expressed by other cells. For primate NK cells, the killer-cell immunoglobulin-like receptors (KIR) are a variable and rapidly evolving family of MHC Class I receptors. Studied here is KIR3DL1/S1, which encodes receptors for highly polymorphic human HLA-A and -B and comprises three ancient allelic lineages that have been preserved by balancing selection throughout human evolution. While the 3DS1 lineage of activating receptors has been conserved, the two 3DL1 lineages of inhibitory receptors were diversified through inter-lineage recombination with each other and with 3DS1. Prominent targets for recombination were D0-domain polymorphisms, which modulate enhancer function, and dimorphism at position 283 in the D2 domain, which influences inhibitory function. In African populations, unequal crossing over between the 3DL1 and 3DL2 genes produced a deleted KIR haplotype in which the telomeric “half” was reduced to a single fusion gene with functional properties distinct from its 3DL1 and 3DL2 parents. Conversely, in Eurasian populations, duplication of the KIR3DL1/S1 locus by unequal crossing over has enabled individuals to carry and express alleles of all three KIR3DL1/S1 lineages. These results demonstrate how meiotic recombination combines with an ancient, preserved diversity to create new KIR phenotypes upon which natural selection acts. A consequence of such recombination is to blur the distinction between alleles and loci in the rapidly evolving human KIR gene family.

    Footnotes

    | Table of Contents

    Preprint Server